Safety and Pharmacokinetics of XL647 Administered Orally to Subjects With Solid Tumors
Clinical trial NCT00086528 · COMPLETED
Trial details
- NCT number
- NCT00086528
- Sponsor
- Kadmon Corporation, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Primary completion
- 2007-07-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.